证券记录 · 已归档季度
WST
West Pharmaceutical Services, Inc. · Healthcare · Medical - Instruments & Supplies
12被追踪持有人
-1Δ持有人
4.43M持有股份
$1.33B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -7.7% ·
股份流向 -17.0% ·
净新建仓位 -8.3%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 162 | +3 | 50.44M | $18.07B | +8 | −4 |
| Q1 2026 | 161 | -2 | 49.75M | $12.46B | +4 | −7 |
| Q4 2025 | 162 | +3 | 53.70M | $14.74B | +5 | −1 |
| Q3 2025 | 21 | -1 | 26.99M | $7.08B | — | −2 |
| Q2 2025 | 20 | 0 | 24.84M | $5.43B | +1 | −1 |
| Q1 2025 | 17 | +2 | 8.37M | $1.87B | +2 | — |
| Q4 2024 | 15 | +2 | 8.55M | $2.80B | +2 | — |
| Q3 2024 | 12 | -1 | 4.43M | $1.33B | — | −1 |
| Q2 2024 | 13 | — | 5.33M | $1.75B | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 1.74M | +0.7% | $520.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 1.74M | +0.7% | $520.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.26M | -25.5% | $378.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.26M | -25.5% | $378.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Norges Bank ✦ (被动) | 865.94K | -0.1% | $259.92M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Adage Capital Partners ✦ | 178.41K | +5.0% | $53.55M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 144.72K | +75.7% | $43.44M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | Marshall Wace ✦ | 128.26K | +167.3% | $38.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Marshall Wace ✦ | 128.26K | +167.3% | $38.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Marshall Wace ✦ | 128.26K | +167.3% | $38.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 48.13K | -82.8% | $14.45M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 48.13K | -82.8% | $14.45M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 28.74K | -0.1% | $8.63M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 15.26K | -13.1% | $4.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 15.26K | -13.1% | $4.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 7.92K | -48.0% | $2.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 7.92K | -48.0% | $2.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Wellington Management ✦ | 6.56K | +13.9% | $1.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Wellington Management ✦ | 6.56K | +13.9% | $1.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Wellington Management ✦ | 6.56K | +13.9% | $1.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 2.16K | +2.5% | $648,946 | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Millennium Management | $129.73M | 曾为 0.1% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 749 持有人, 70.07M 股份, $16.37B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
Aug 06
SC 13G — FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据